Fredag 2 Januari | 10:04:30 Europe / Stockholm
Svenska | English

BioStock

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Alzinova comments on SEK 50 million rights issue
2025-12-30 08:53:00

From 6 to 20 February, Alzinova will carry out an 80 per cent secured rights issue of units that can initially provide the company with approximately SEK 50 million. The issue is carried out to strengthen the company’s financial position ahead of continued partnership discussions and preparations for phase II with the vaccine candidate ALZ-101. BioStock contacted CEO Tord Labuda and CFO Erik Kullgren to clarify questions regarding the structure and to have a look ahead.

Read more at biostock.se:

Alzinova comments on the issue of SEK 50 million
 
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter 
Follow BioStock on social media: LinkedIn and Facebook!  
 
About BioStock 
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.  
BioStock – Connecting Innovation & Capital. 

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden